CNBX Pharmaceuticals Inc. Annual Depreciation in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2024.
  • CNBX Pharmaceuticals Inc. Depreciation for the quarter ending November 30, 2024 was $0.000, a 100% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2024 was $72.3K, a 55.4% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2023 was $162K, a 18.4% decline from 2022.
  • CNBX Pharmaceuticals Inc. annual Depreciation for 2022 was $199K, a 10.1% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $72.3K -$89.7K -55.4% Sep 1, 2023 Aug 31, 2024 10-K 2024-11-29
2023 $162K -$36.5K -18.4% Sep 1, 2022 Aug 31, 2023 10-K 2024-11-29
2022 $199K -$22.4K -10.1% Sep 1, 2021 Aug 31, 2022 10-K 2023-11-30
2021 $221K +$5.77K +2.68% Sep 1, 2020 Aug 31, 2021 10-K 2022-11-30
2020 $215K +$26.2K +13.9% Sep 1, 2019 Aug 31, 2020 10-K 2021-11-29
2019 $189K +$100K +114% Sep 1, 2018 Aug 31, 2019 10-K 2020-11-04
2018 $88.4K +$81.4K +1160% Sep 1, 2017 Aug 31, 2018 10-K 2019-11-29
2017 $7.02K +$5.44K +345% Sep 1, 2016 Aug 31, 2017 10-K 2018-11-29
2016 $1.58K +$273 +20.9% Sep 1, 2015 Aug 31, 2016 10-K 2017-12-08
2015 $1.3K +$1.22K +1416% Sep 1, 2014 Aug 31, 2015 10-K 2016-12-13
2014 $86.00 +$86.00 Sep 1, 2013 Aug 31, 2014 10-K 2016-01-07
2013 $0 Sep 1, 2012 Aug 31, 2013 10-K/A 2015-10-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.